AbbVie Inc. earnings release
Outlookissuedguidance
Earnings release · ABBV
AbbVie Reports Third-Quarter 2026 Financial Results
AbbVie Inc. · Filed · SEC Form 8-K, Item 2.02
Revenue
$17.404 billion
+10.3% vs a year ago
EPS
$2.37
not detected
Guidance
raisedoutlook statement
Automated extract. The items below were picked out of the company's press release by software and may be wrong or incomplete.
Please read the original before relying on any figure. Not investment advice.
Why it matters
Revenue grew 10.3% year on year to $17.404 billion, and EPS was $2.37. The company lifted its guidance, which is usually read as management's view of coming periods improving.
Written automatically by Stocknote's note engine from the figures on this page and the company's previous release. Every number in this note is checked against those figures. Not investment advice.
What the company states
Revenue
$17.404 billion +10.3% vs a year ago
…Delivers Third-Quarter Net Revenues of $17.404 Billion, an Increase of 10.3 Percent on a Reported Basis or 10.5 Percent on an Operational Ba…
EPS
$2.37
…Reports Third-Quarter Diluted EPS of $2.37 on a GAAP Basis, an Increase of Over 100.0 Percent; Adjusted Diluted EPS of $3.82, an Increase of Over…
Guidance
Guidance raised
…Raises 2026 Adjusted Diluted EPS Guidance Range from $13.76 - $13.96 to $13.95 - $13.99, which Includes an Unfavorable Impact of $0.69 Per Share Related to Acquired IPR&D and Milestones Expense Incurred Year-To-Date Throu | Given our strong outlook and significant momentum, we ar…
Other releases from AbbVie Inc.
All →
Disclaimer: This page is generated automatically from public SEC filings for information only. Stocknote does not edit the company's release and does not guarantee the accuracy of the extracted items. Read the full disclaimer here.